Restless Legs Syndrome
📧 Sign up to get email alerts when something new happens for Restless Legs Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-10-26FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)
FDA approved a supplemental application for Pramipexole dihydrochloride from ScieGen Pharmaceuticals Inc, confirming approval of a generic p…
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for ropinirole from Bionpharma Inc.
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Marlex Pharmaceuticals Inc)
The FDA approved a supplemental application for ropinirole submitted by Marlex Pharmaceuticals Inc. This action authorizes changes to an alr…
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Dr. Reddys Laboratories Limited)
FDA approved a supplemental application for ropinirole submitted by Dr. Reddys Laboratories Limited under ANDA 201576.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS) [Phase 2]
Phase 2 pharmacokinetic study evaluating pramipexole in pediatric patients with idiopathic Restless Legs Syndrome who are on stable optimize…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-09-28FDA Approved: ROPINIROLE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s supplemental application for ropinirole, a generic ropinirole product.
-
FDA approval · 2015-09-22FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's supplemental application for pramipexole dihydrochloride (Glenmark). The approval pertains to a generic version of t…
-
FDA approval · 2015-09-22FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Aurobindo Pharma Limited (ANDA 202633).
-
FDA approval · 2015-09-10FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc.
-
FDA approval · 2015-08-07FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved a generic pramipexole dihydrochloride product from Dr. Reddy's Laboratories Limited; indicated for Parkinson's disease and rest…
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome [Phase 2]
A Phase 2 dose-escalation trial of rotigotine in pediatric patients with Restless Legs Syndrome has completed, with results posted on 2015-0…
-
CLINICAL_TRIALS withdrawal · 2015-06-30Clinical Trial Update: IV Iron Treatment of Restless Legs Syndrome [Phase 2]
A Phase 2 clinical trial evaluating intravenous iron for restless legs syndrome was withdrawn; no results are reported.
-
CLINICAL_TRIALS withdrawal · 2015-06-16Clinical Trial Update: Vasculaire Leg Compression Device for the Treatment of Restless Legs Syndrome - A Prospective Clinical Study [NA]
A prospective clinical study evaluating a vascular leg compression device for restless legs syndrome has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments [Phase 2]
Phase 2 trial assessing the safety of three dose regimens of iron sucrose for Restless Legs Syndrome based on clinical assessments.
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: Effects of Gabapentin Enacarbil on Arousals, Heart Rate, Blood Pressure and PLMs in Restless Legs Syndrome [Phase 4]
Phase 4 trial evaluating the effects of gabapentin enacarbil on arousals, heart rate, blood pressure, and periodic limb movements in patient…
-
FDA approval · 2015-04-15FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for bromocriptine mesylate (Padagis US LLC).
-
FDA approval · 2015-04-13FDA Approved: ROPINIROLE HYDROCHLORIDE — Supplemental Application (SOLCO HEALTHCARE US, LLC)
The FDA approved a supplemental Abbreviated New Drug Application to authorize a generic ropinirole hydrochloride product from Solco Healthca…
-
CLINICAL_TRIALS research · 2015-04-06Clinical Trial Update: Vitamin D in the Treatment of Primary Restless Legs Syndrome [Phase 2, Phase 3]
This entry reports on a Phase 2/3 clinical trial evaluating vitamin D for primary restless legs syndrome. The status is currently UNKNOWN.
-
FDA approval · 2015-02-26FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for NEUPRO (rotigotine) from UCB, Inc., resulting in updated labeling. This action reflects a ch…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Altered Brain GABA and Glutamate in Restless Legs Syndrome
A completed clinical trial investigated alterations in brain GABA and glutamate levels in individuals with Restless legs syndrome.
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy [Phase 4]
This is a Phase 4 clinical trial update from the University of Zurich investigating restless legs syndrome associated with iron deficiency a…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study [Phase 4]
Phase 4 post-marketing commitment trial evaluating gabapentin enacarbil for adults with Restless Legs Syndrome has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis [Phase 3]
Phase 3 trial assessing the safety and efficacy of a rotigotine transdermal patch for restless legs syndrome in patients with end-stage rena…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: ASP8825 - Study in Patients With Restless Legs Syndrome [Phase 2]
A Phase 2 study of ASP8825 for restless legs syndrome has completed.
-
CLINICAL_TRIALS research · 2014-10-20Clinical Trial Update: Named Patient Program With Rotigotine Transdermal System
This document reports an update on the named patient program for the rotigotine transdermal system, noting that the program has completed.